Bronte Capital Management Pty Ltd. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 41 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bronte Capital Management Pty Ltd. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$6,882,000
+88.1%
1,156,626
+100.0%
0.39%
+28.3%
Q1 2022$3,658,000
+74.0%
578,313
+7.6%
0.31%
+120.9%
Q4 2021$2,102,000
-20.7%
537,584
-2.1%
0.14%
-28.4%
Q3 2021$2,651,000
-24.4%
548,8360.0%0.19%
-22.4%
Q2 2021$3,507,000
+1.4%
548,836
-0.3%
0.25%
-36.2%
Q1 2021$3,458,000
-5.6%
550,679
+3.6%
0.39%
-32.3%
Q4 2020$3,662,000
+78.5%
531,5100.0%0.58%
+60.4%
Q3 2020$2,052,000531,5100.36%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders